Tops & Flops Stocks
Security | Change (%) | 1w | 1m | 1y ▲ | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Avenue Therapeutics Inc. | 22.820% | -12.419% | -21.588% | -87.239% | -27.016% | - | - |
Aclaris Therapeutics Inc | 0.860% | -4.664% | -2.281% | -86.247% | 17.263% | -94.624% | - |
Endo International | - | 0.000% | 400.000% | -85.714% | -75.000% | -99.798% | -99.848% |
Eagle Pharmaceuticals Inc | -0.460% | -13.061% | -7.792% | -83.228% | -4.911% | -87.898% | -90.909% |
Cara Therapeutics Inc. | 3.590% | 1.270% | -23.912% | -83.219% | -8.003% | -97.089% | -96.292% |
Seres Therapeutics Inc | 14.410% | 28.557% | 7.417% | -82.581% | -40.962% | -95.582% | - |
Brainstorm Cell | -5.760% | -2.456% | -5.429% | -82.011% | 114.009% | -83.450% | - |
Atara Biotherapeutics Inc. | -0.190% | 2.468% | 7.358% | -73.613% | 26.821% | -94.515% | - |
Coherus Bioscien. | 3.130% | -1.400% | -13.741% | -71.050% | -37.434% | -85.024% | -85.727% |
Salarius Pharmaceuticals Inc. | -1.840% | 1.429% | 0.472% | -70.417% | -23.243% | -98.377% | -99.993% |
Karyopharm Therapeutics Inc. | -2.870% | -3.707% | -25.049% | -69.408% | 19.731% | -87.511% | - |
AB Science S.A. | -0.100% | -2.117% | -20.573% | -67.794% | -46.795% | -87.778% | -59.457% |
Enanta Pharmaceuticals Inc. | - | -8.065% | -29.193% | -64.596% | 29.545% | -72.195% | -85.524% |
Sangamo Therapeutics Inc. | 4.960% | 1.166% | -21.366% | -63.457% | -15.528% | -95.223% | -95.507% |
Onxeo S.A. | -2.680% | -6.838% | 1.869% | -61.484% | -28.053% | -84.429% | -86.724% |
Prothena Corp. plc | 2.080% | -2.010% | -15.217% | -59.711% | -43.966% | -11.364% | - |
Kala Pharmaceuticals Inc. | -4.170% | -2.954% | -18.728% | -57.154% | -11.810% | -98.276% | - |
Dainippon Sumitomo Pharma | 1.690% | 3.448% | 0.840% | -57.143% | -17.808% | -82.734% | -87.668% |
DBV Technologies S.A. | 1.450% | -2.181% | -7.375% | -56.749% | -33.720% | -88.134% | -92.880% |
Anavex Life Sciences Corp | 3.860% | -9.753% | -31.227% | -56.514% | -62.973% | -68.520% | 28.440% |
Avid Bioservices Inc | 5.380% | 15.126% | 7.031% | -56.090% | 12.295% | -61.517% | 57.743% |
Advicenne | -2.840% | -1.561% | -18.408% | -56.032% | -36.557% | -86.149% | - |